Redcare Pharmacy NV (BIT:1RDC)

Redcare Pharmacy NV Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	94.79	96.89	84.16	66.78	247.41	90.49
Short-Term Investments	220.92	80.66	120	113.32	36.42	37.77
Cash & Short-Term Investments	315.71	177.56	204.16	180.1	283.83	128.26
Cash Growth	36.54%	-13.03%	13.36%	-36.55%	121.30%	13.27%
Accounts Receivable	119.18	109.87	103.13	30	27.92	29.98
Other Receivables	-	14.99	16.17	10.94	8.25	-
Receivables	119.18	124.86	119.31	40.95	36.16	29.98
Inventory	161.8	153.82	135.79	99.71	96.62	81.24
Prepaid Expenses	68.79	17.99	10.89	6.57	3.7	4.71
Other Current Assets	-	25.79	29.38	16.59	12.45	9.91
Total Current Assets	665.48	500.02	499.52	343.92	432.76	254.09
Property, Plant & Equipment	160.14	82.57	86.91	85.44	78.26	74.55
Long-Term Investments	1.42	1.42	1.31	1.27	1.47	1.77
Goodwill	-	277.5	277.5	169.57	153.13	129.12
Other Intangible Assets	404.66	133.82	150.61	119.43	104.35	75.54
Long-Term Deferred Tax Assets	1.41	1.41	2.3	0.46	-	0.12
Other Long-Term Assets	8.94	6.55	3.46	9.39	13.11	1.73
Total Assets	1,242	1,003	1,022	729.47	783.08	536.91
Accounts Payable	245.7	175.29	152	68.94	78.12	51.32
Accrued Expenses	-	55.56	56.79	38.64	36.38	15.65
Short-Term Debt	1.06	-	-	-	0.04	0.04
Current Portion of Long-Term Debt	77.01	1.63	1.63	1.67	1.63	-
Current Portion of Leases	-	8.1	7.15	5.88	4.74	5.38
Current Income Taxes Payable	-	0.46	0.57	0.24	0.78	0.39
Other Current Liabilities	65.93	8.7	5.6	3.94	2.41	1.82
Total Current Liabilities	389.7	249.73	223.72	119.31	124.09	74.61
Long-Term Debt	306.81	209.14	204.35	199.75	195.38	4.08
Long-Term Leases	-	27.68	30.68	27.59	26.06	28.73
Long-Term Deferred Tax Liabilities	15.31	3.57	6.32	7.89	13.55	4.35
Other Long-Term Liabilities	-	-	-	14.62	2.65	-
Total Liabilities	713.51	493.32	469.56	374.84	367.66	111.77
Common Stock	0.4	0.4	0.4	0.36	0.36	0.35
Additional Paid-In Capital	755.44	754.9	733.03	570.7	566.54	551.67
Retained Earnings	-330.09	-324.29	-279.26	-285.43	-207.78	-133.72
Comprehensive Income & Other	82.95	52.97	68.03	69	56.3	6.84
Total Common Equity	508.7	483.98	522.19	354.63	415.41	425.14
Minority Interest	19.84	25.99	29.84	-	-	-
Shareholders' Equity	528.54	509.97	552.03	354.63	415.41	425.14
Total Liabilities & Equity	1,242	1,003	1,022	729.47	783.08	536.91
Total Debt	384.88	246.54	243.79	234.89	227.84	38.23
Net Cash (Debt)	-69.17	-68.99	-39.63	-54.79	55.99	90.02
Net Cash Growth	-	-	-	-	-37.80%	-
Net Cash Per Share	-3.44	-3.44	-2.06	-3.05	3.13	6.26
Filing Date Shares Outstanding	20.34	20.34	20.2	18.2	18.1	17.94
Total Common Shares Outstanding	20.34	20.34	20.2	18.2	18.1	17.94
Working Capital	275.79	250.29	275.79	224.61	308.68	179.47
Book Value Per Share	25.01	23.79	25.85	19.49	22.96	23.70
Tangible Book Value	104.04	72.67	94.09	65.63	157.94	220.48
Tangible Book Value Per Share	5.11	3.57	4.66	3.61	8.73	12.29
Land	-	6.61	5.3	6.43	37.88	40.95
Machinery	-	53.45	49.74	43.53	35.25	12.29
Construction In Progress	-	1.06	0.73	3.82	5.92	22.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.